0

Phase Transformation of Erythromycin A Dihydrate During Fluid Bed Drying

Meike Römer, Jyrki Heinämäki, Inna Miroshnyk, Niina Kivikero, Niklas Sandler, Jukka Rantanen, Jouko Yliruusi

J Pharm Sci. 2008 Sep;97(9):4020-9.

PMID: 18200525

Abstract:

An in-line near infrared (NIR) spectrometer was employed to monitor phase transformations of erythromycin dihydrate during a miniaturized fluid bed drying process. The pellets, containing 50% (w/w) erythromycin dihydrate and 50% (w/w) microcrystalline cellulose, were dried at 30, 45, and 60 degrees C. Principal component analysis was used to determine solid-state changes. For this purpose the wavelength range of 1360-2000 nm was selected and preprocessed to remove multiplicative effects. Transformation to erythromycin dehydrate was observed for the pellets dried at 45 and 60 degrees C by NIR spectrometry and X-ray powder diffractometry (XRPD). The formation of erythromycin dehydrate was observed at a moisture content 1.4% (w/w) (mass of water per dry mass of sample) while at 1.8% (w/w) neither XRPD nor NIR were able to detect dehydration. Transformation to erythromycin dehydrate therefore depends strongly on the moisture content of the pellets.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP59319721 Erythromycin A dihydrate Erythromycin A dihydrate 59319-72-1 Price
qrcode